AGBL2 and rheumatoid arthritis: The results of the current study show that in CCP2+ at-risk individuals with MSK symptoms, but without clinical synovitis, the majority of progressors go through a stage of US subclinical joint inflammation prior to developing inflammatory arthritis; this represents a distinct stage of the ‘RA continuum’.